Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients

Thrombosis Research

Volumn 128, Issue 5, 2011, Pages

  Lukasik, Maria ^a   Dworacki, Grzegorz ^a   Michalak, Slawomir ^a,b   Kufel Grabowska, Joanna ^a   Golanski, Jacek ^c   Watala, Cezary ^c   Kozubski, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Aspirin; CD40L; Ischaemic stroke; Leukocyte platelet aggregates; P selectin; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BIOLOGICAL MARKER; CD40 LIGAND; PADGEM PROTEIN; THROMBOXANE B2;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMPEDANCE; LEUKOCYTE PLATELET AGGREGATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STROKE; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; TREATMENT DURATION;

AGED; ASPIRIN; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CD40 LIGAND; CYCLOOXYGENASE 1; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MONOCYTES; P-SELECTIN; PLATELET ADHESIVENESS; PLATELET AGGREGATION INHIBITORS; STROKE; THROMBOXANE B2;

EID: 80055080920     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.06.016     Document Type: Article

References (35)

1. H. Hu, L. Zhu, Z. Huang, M. Chatterjee, W. Zhang, and N. Li Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus Thromb Haemost 104 6 2010 1184 1192
2. G. Davì, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 24 2007 2482 2494
3. A.D. Michelson, M.R. Barnard, H. Hechtman, H. MacGregor, R.J. Connolly, and J. Loscalzo In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function Proc Natl Acad Sci USA 93 1996 11877 11883
4. A. Zirlik, C. Maier, N. Gerdes, L. MacFarlane, J. Soosairajah, and U. Bavendiek CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1 Circulation 115 2007 1571 1580 (Pubitemid 46648642)
5. C.D. Garlichs, S. Eskafi, D. Raaz, A. Schmidt, J. Ludwig, and M. Herrmann Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets Heart 86 2001 649 655 (Pubitemid 33086881)
6. A. Choudhury, I. Chung, N. Panja, J. Patel, and G.Y. Lip Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation Chest 134 2008 574 581
7. P. Ferroni, S. Basili, A. Falco, and G. Davì Platelet activation in type 2 diabetes mellitus Thromb Haemost 2 2004 1282 1291 (Pubitemid 40186123)
8. J.K. Cha, M.H. Jeong, J.Y. Jang, H.R. Bae, Y.J. Lim, and J.S. Kim Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke Cerebrovasc Dis 16 2003 376 382
9. M. Cataneo Laboratory detection of 'aspirin resistance': what test should we use (if any)? Eur Heart J 28 2007 1673 1675
10. C. Weber Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells Circulation 91 1995 1914 1917
11. I. Ikonomidis, F. Andreotti, E. Economou, C. Stefanadis, P. Toutouzas, and P. Nihoyannopoulos Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin Circulation 100 1999 793 798 (Pubitemid 29398875)
12. S. Solheim, H. Arnesen, L. Eikvar, M. Hurlen, and I. Seljeflot Influence of aspirin on inflammatory markers in patients after myocardial infarction Am J Cardiol 92 2003 843 845 (Pubitemid 37163584)
13. S. Solheim, A.A. Pettersen, H. Arnesen, and I. Seljeflot No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease Thromb Haemost 96 2006 660 664 (Pubitemid 44782547)
14. N. Li, H. Hu, and P. Hjemdahl Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry Thromb Res 111 2003 165 170 (Pubitemid 37532855)
15. C.S. Rinder, L.A. Student, J.L. Bonan, H.M. Rinder, and B.R. Smith Aspirin does not inhibit adenosine diphosphate-induced platelet alpha- granule release Blood 82 1993 505 512 (Pubitemid 23206114)
16. M.E. McKenzie, A.I. Malinin, C.R. Bell, A. Dzhanashvili, E.D. Horowitz, and B.R. Oshrine Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets Blood Coagul Fibrinolysis 14 2003 249 253 (Pubitemid 36589146)
17. H.P. Adams Jr., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, and D.L. Gordon Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41 (Pubitemid 23014379)
18. J. Bamford, P. Sandercock, M. Dennis, J. Burn, and C. Warlow Classification and natural history of clinically identifiable subtypes of cerebral infarction Lancet 337 1991 1521 1526
19. H.K. Yip, S.S. Chen, J.S. Liu, H.W. Chang, Y.F. Kao, and M.Y. Lan Serial changes in platelet activation in patients after ischemic stroke. Role of pharmacodynamic modulation Stroke 35 2004 1683 1687 (Pubitemid 38823647)
20. N.W. Tsai, W.N. Chang, C.F. Shaw, C.R. Jan, H.W. Chang, and C.R. Huang Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke Thromb Res 124 2009 213 218
21. D.J. McCabe, P. Harrison, I.J. Mackie, P.S. Sidhu, G. Purdy, and A.S. Lawrie Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack Br J Haematol 125 6 2004 777 787 (Pubitemid 38813605)
22. M. Boncler, B. Luzak, M. Rozalski, J. Golanski, B. Rychlik, and C. Watala Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein Thromb Res 119 2007 209 216 (Pubitemid 44765069)
23. N.A. Chronos, D.J. Wilson, S.L. Janes, R.A. Hutton, N.P. Buller, and A.H. Goodall Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets Clin Sci 87 1994 575 580 (Pubitemid 24353473)
24. A. Szczeklik, M. Krzanowski, P. Gora, and J. Radwan Antiplatelet drugs and generation of thrombin clotting blood Blood 80 1992 2006 2011
25. R.K. Kharbanda, B. Walton, M. Allen, N. Klein, A.D. Hingorani, and R.J. MacAllister Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin Circulation 105 2002 2600 2604 (Pubitemid 34596035)
26. Y.J. Cao, Y.M. Wang, J. Zhang, Y.J. Zeng, and C.F. Liu The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction J Thromb Thrombolysis 27 2009 233 238
27. L. Zhao, L. Gray, J. Leonardi-Bee, C.S. Weaver, S. Heptinstall, and P.M. Bath Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischemic stroke Platelets 17 2006 100 104 (Pubitemid 43155616)
28. A. Undas, M. Celinska-Löwenhoff, T.B. Domagala, T. Iwaniec, J. Dropinski, and T. Löwenhoff Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia Thromb Haemost 94 2005 193 199 (Pubitemid 40974724)
29. L.M. Blanco-Colio, J.L. Martín-Ventura, E. de Teresa, C. Farsang, A. Gaw, and G. Gensini ACTFAST investigators. Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST Kidney Int Suppl 111 2008 S60 S63
30. P.M. Riker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979 (Pubitemid 27152782)
31. A.L. Frelinger III, Y.F. Li, M.D. Linden, M.L. Fox, D.J. Christie, and M.I. Furman Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization Circulation 120 2009 2586 2596
32. T. Gremmel, C.W. Kopp, D. Seidinger, G.A. Giurgea, R. Koppensteiner, and S. Steiner The formation of monocyte-platelet aggregates is independent of on-treatment residual agonists'-inducible platelet reactivity Atherosclerosis 207 2009 608 613
33. M. Lukasik, G. Dworacki, J. Kufel, C. Watala, and W. Kozubski Leukocyte-platelet complex formation as a predictor of clinical outcome in the acute and convalescent phases of ischemic stroke Neurology 74 S2 2010 A145
34. P.A. Gurbel, K.P. Bliden, J. DiChiara, J. Newcomer, W. Weng, and N.K. Neerchal Evaluation of dose-related effects of aspirin on platelet function. Results from the aspirin-induced platelet effect (ASPECT) study Circulation 115 2007 3156 3164 (Pubitemid 47012230)
35. T. Furuno, F. Yamasaki, T. Yokoyama, K. Sato, T. Sato, and Y. Doi Effects of various doses of aspirin on platelet activity and endothelial function Heart Vessels 26 2011 267 273